Breaking News Instant updates and real-time market news.

BBIO

BridgeBio

$29.06

-0.58 (-1.96%)

08:01
12/02/19
12/02
08:01
12/02/19
08:01

PellePharm completes enrollment of Patidegib 2% pivotal Phase 3 clinical trial

PellePharm, a BridgeBio Pharma company, announced the completion of enrollment for its pivotal Phase 3 clinical trial of Patidegib Topical Gel 2% vs. vehicle gel in patients with Gorlin Syndrome. PellePharm is a late clinical-stage biopharmaceutical company committed to targeting rare forms of basal cell carcinoma.

  • 03

    Dec

BBIO BridgeBio
$29.06

-0.58 (-1.96%)

07/26/19
07/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dentsply Sirona (XRAY) initiated with an In Line at Evercore ISI. 2. BridgeBio (BBIO) initiated with an Outperform at Raymond James. 3. Crispr Therapeutics (CRSP) initiated with a Buy at Canaccord. 4. GeoPark (GPRK) initiated with a Buy at GMP Securities. 5. Neon Therapeutics (NTGN), Gritstone Oncology (GRTS), and Cue Biopharma (CUE) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/19
BTIG
09/13/19
NO CHANGE
Target $56
BTIG
Buy
Eidos Therapeutics price target raised to $56 from $38 at BTIG
BTIG analyst Thomas Shrader raised his price target on Eidos Therapeutics (EIDX) to $56 and kept his Buy rating after the decision by its board to reject an acquisition offer from parent company BridgeBio (BBIO) to buy all of its outstanding stock. The analyst notes that he always believed the combined entity would not be a more attractive investment, saying he is positive on the company's "declaration of independence". Shrader further cites the added revenue contribution expected from Eidos Therapeutics' deal with Alexion (ALXN) to develop and commercialize AG10 in Japan.
10/18/19
PIPR
10/18/19
NO CHANGE
Target $50
PIPR
Overweight
BridgeBio has 'best-in-class' potential in achondroplasia, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren reiterates an Overweight rating on BridgeBio with a $50 price target after new preclinical data for infigratinib in achondroplasia were presented. The drug is effective at lower and less frequent dosing regimens than previously tested, says the analyst, who believes infigratinib could capture 50% achondroplasia market share by 2035, which could amount to over $1.5B in sales. He sees "best-in-class potential" for the drug.
11/19/19
PIPR
11/19/19
NO CHANGE
Target $75
PIPR
Overweight
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren raised his price target for Eidos Therapeutics to $75 from $55 and reiterates an Overweight rating on the shares following the initial AG10 long-term outcomes data. The stock closed Monday up 18% to $55.02. After speaking with a key opinion leader, the analyst believes that BridgeBio (BBIO) and Eidos's AG10 appears superior to the anticipated blockbuster Vyndaqel/tafamidis. Van Buren says he's using a "conservative" one-times multiple on a 2030 AG10 sales estimate. He believes the ATTR cardiomyopathy market could grow to an eventual $5B-$10B opportunity as the pool of diagnosed patients expands several-fold. In addition, the new price target does not include a premium for a takeout, which is more likely following the AG10 data, Van Buren tells investors in a research note.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$30.56

0.71 (2.38%)

, AAPL

Apple

$270.71

2.09 (0.78%)

17:51
12/11/19
12/11
17:51
12/11/19
17:51
Hot Stocks
Twitter announces support for iOS Live Photos that will show as GIFs »

Earlier today Twitter…

TWTR

Twitter

$30.56

0.71 (2.38%)

AAPL

Apple

$270.71

2.09 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

GVA

Granite Construction

$26.29

0.97 (3.83%)

17:46
12/11/19
12/11
17:46
12/11/19
17:46
Hot Stocks
Granite Construction awarded $14M site development project in Illinois »

Granite's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNRL

Brigham Minerals

$18.60

0.4 (2.20%)

17:45
12/11/19
12/11
17:45
12/11/19
17:45
Syndicate
Brigham Minerals 11M share Secondary priced at $18.10 »

Credit Suisse, Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

KHC

Kraft Heinz

$31.59

-0.29 (-0.91%)

17:39
12/11/19
12/11
17:39
12/11/19
17:39
Initiation
Kraft Heinz initiated  »

Kraft Heinz resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$66.17

-0.48 (-0.72%)

17:37
12/11/19
12/11
17:37
12/11/19
17:37
Initiation
Kellogg initiated  »

Kellogg resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.32

-0.085 (-0.59%)

17:34
12/11/19
12/11
17:34
12/11/19
17:34
Hot Stocks
UAW ratifies CBA with Fiat Chrysler »

UAW Fiat Chrysler U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

FLO

Flowers Foods

$21.54

-0.04 (-0.19%)

17:27
12/11/19
12/11
17:27
12/11/19
17:27
Initiation
Flowers Foods initiated  »

Flowers Foods resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:25
12/11/19
12/11
17:25
12/11/19
17:25
General news
U.S. Treasury posted a -$208.8 B budget deficit in November »

U.S. Treasury posted a…

NOMD

Nomad Foods

$20.54

-0.12 (-0.58%)

17:23
12/11/19
12/11
17:23
12/11/19
17:23
Initiation
Nomad Foods initiated  »

Nomad Foods resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMPX

LMP Automotive

$15.05

1.75 (13.16%)

17:23
12/11/19
12/11
17:23
12/11/19
17:23
Hot Stocks
LMP Automotive Chairman Samer Tawfik buys over $1.7M in company shares »

LMP Automotive Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$28.91

0.1 (0.35%)

17:21
12/11/19
12/11
17:21
12/11/19
17:21
Syndicate
Breaking Syndicate news story on Triumph Group »

Triumph Group files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKC

McCormick

$170.70

-0.635 (-0.37%)

17:12
12/11/19
12/11
17:12
12/11/19
17:12
Initiation
McCormick initiated  »

McCormick resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLR

Continental Resources

$33.37

0.27 (0.82%)

17:10
12/11/19
12/11
17:10
12/11/19
17:10
Conference/Events
Continental Resources to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$51.57

-1.67 (-3.14%)

, K

Kellogg

$66.17

-0.48 (-0.72%)

17:08
12/11/19
12/11
17:08
12/11/19
17:08
Initiation
General Mills, Kellogg initiated  »

General Mills resumed…

GIS

General Mills

$51.57

-1.67 (-3.14%)

K

Kellogg

$66.17

-0.48 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CEI

Camber Energy

$2.05

0.86 (72.27%)

17:05
12/11/19
12/11
17:05
12/11/19
17:05
Hot Stocks
Camber Energy responds to unusual market activity »

Camber Energy commented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGEN

Miragen Therapeutics

$0.69

0.0554 (8.73%)

17:04
12/11/19
12/11
17:04
12/11/19
17:04
Conference/Events
Miragen Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGI

Alamos Gold

$5.57

0.205 (3.82%)

17:03
12/11/19
12/11
17:03
12/11/19
17:03
Hot Stocks
Alamos Gold sees FY20 production 425K-465K ounces of gold »

Alamos Gold provided 2020…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMNFF

MedMen

$0.00

(0.00%)

17:02
12/11/19
12/11
17:02
12/11/19
17:02
Earnings
MedMen sees positive adjusted EBITDA in Q121, and positive FCF in Q321 »

The company anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CPB

Campbell Soup

$48.00

-0.37 (-0.76%)

17:02
12/11/19
12/11
17:02
12/11/19
17:02
Initiation
Campbell Soup initiated  »

Campbell Soup resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMNFF

MedMen

$0.00

(0.00%)

17:00
12/11/19
12/11
17:00
12/11/19
17:00
Earnings
MedMen sees FY20 revenue $225M - $245M, consensus $212.69M »

Sees FY21 revenue $450 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

XOM

Exxon Mobil

$68.95

-0.11 (-0.16%)

16:59
12/11/19
12/11
16:59
12/11/19
16:59
Hot Stocks
Exxon Mobil's Milton sells 13,569 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SJM

J.M. Smucker

$104.42

-1.64 (-1.55%)

16:57
12/11/19
12/11
16:57
12/11/19
16:57
Initiation
J.M. Smucker initiated  »

J.M. Smucker resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

16:55
12/11/19
12/11
16:55
12/11/19
16:55
Conference/Events
Oppenheimer healthcare analysts to hold a KOL dinner meeting »

Analysts hold a Cardiac…

MMNFF

MedMen

$0.00

(0.00%)

16:54
12/11/19
12/11
16:54
12/11/19
16:54
Hot Stocks
MedMen granted delivery-only license by the city of Mountain View, California »

On November 21, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CAG

Conagra Brands

$28.64

-0.58 (-1.98%)

16:53
12/11/19
12/11
16:53
12/11/19
16:53
Initiation
Conagra Brands initiated  »

Conagra Brands resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.